Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis - PubMed (original) (raw)
Clinical Trial
. 2002 Nov 7;347(19):1493-9.
doi: 10.1056/NEJMoa013508.
Affiliations
- PMID: 12421891
- DOI: 10.1056/NEJMoa013508
Free article
Clinical Trial
Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis
Ana R Sousa et al. N Engl J Med. 2002.
Free article
Abstract
Background: Patients with asthma who have aspirin sensitivity have greater cysteinyl leukotriene production and greater airway hyperresponsiveness to the effects of inhaled cysteinyl leukotrienes than their aspirin-tolerant counterparts. We hypothesized that the latter effect reflects elevated expression of the cysteinyl leukotriene receptor CysLT1 on inflammatory cells in the target organ and that its expression is down-regulated by aspirin desensitization.
Methods: We obtained nasal-biopsy specimens from 22 aspirin-sensitive and 12 non-aspirin-sensitive patients with chronic rhinosinusitis and nasal polyps. Additional specimens were then obtained from subgroups of the aspirin-sensitive patients after intranasal application of lysine aspirin or placebo for two weeks (five and four patients, respectively) or for six months (five and four patients, respectively). The numbers of leukocytes expressing the CysLT1 and leukotriene B4 (LTB4) receptors per unit area of sections of the nasal submucosa were determined by immunohistochemistry.
Results: The absolute number of cells expressing the CysLT1 receptor was significantly higher in the aspirin-sensitive patients than in the non-aspirin-sensitive patients (median, 542 cells per square millimeter [range, 148 to 1390] vs. 116 cells per square millimeter [range, 40 to 259]; P<0.001). The percentage of CD45+ leukocytes expressing the CysLT1 receptor was also higher in the aspirin-sensitive subjects (25 percent of CD45+ leukocytes [range, 4 to 50] vs. 5 percent of CD45+ leukocytes [range, 2 to 11]; P<0.001); the percentage of CD45+ leukocytes expressing the LTB4 receptor did not differ significantly between these two groups. Desensitization was associated with a decrease in the numbers of inflammatory cells expressing CysLT1.
Conclusions: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in aspirin-sensitive patients with chronic rhinosinusitis as compared with their non-aspirin-sensitive counterparts and the down-regulation of receptor expression after desensitization to aspirin are probably fundamental in the pathogenesis of aspirin sensitivity and in the mechanism of aspirin desensitization.
Copyright 2002 Massachusetts Medical Society
Comment in
- Leukotriene receptors and aspirin sensitivity.
Arm JP, Austen KF. Arm JP, et al. N Engl J Med. 2002 Nov 7;347(19):1524-6. doi: 10.1056/NEJMe020116. N Engl J Med. 2002. PMID: 12421897 No abstract available.
Similar articles
- Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.
Corrigan C, Mallett K, Ying S, Roberts D, Parikh A, Scadding G, Lee T. Corrigan C, et al. J Allergy Clin Immunol. 2005 Feb;115(2):316-22. doi: 10.1016/j.jaci.2004.10.051. J Allergy Clin Immunol. 2005. PMID: 15696087 - Leukotriene receptors and aspirin sensitivity.
Arm JP, Austen KF. Arm JP, et al. N Engl J Med. 2002 Nov 7;347(19):1524-6. doi: 10.1056/NEJMe020116. N Engl J Med. 2002. PMID: 12421897 No abstract available. - Cysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patients.
Ozen Z, Mumbuc S, Sari I, Baglam T, Karatas E, Kanlikama M. Ozen Z, et al. ORL J Otorhinolaryngol Relat Spec. 2007;69(3):176-80. doi: 10.1159/000099228. Epub 2007 Jan 30. ORL J Otorhinolaryngol Relat Spec. 2007. PMID: 17264534 - Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG, Simon HU, Schmitz-Schumann M. Schapowal AG, et al. Acta Otorhinolaryngol Belg. 1995;49(3):235-50. Acta Otorhinolaryngol Belg. 1995. PMID: 7484142 Review. - Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma.
Platt M, Metson R, Stankovic K. Platt M, et al. Curr Opin Allergy Clin Immunol. 2009 Feb;9(1):23-8. doi: 10.1097/ACI.0b013e32831d8170. Curr Opin Allergy Clin Immunol. 2009. PMID: 19532090 Review.
Cited by
- Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.
Velazquez JR, Teran LM. Velazquez JR, et al. Clin Rev Allergy Immunol. 2013 Aug;45(1):75-86. doi: 10.1007/s12016-012-8340-0. Clin Rev Allergy Immunol. 2013. PMID: 23184151 Review. - Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW, Liu L, Huyett P, Negri J, Payne SC, Borish L. Steinke JW, et al. J Allergy Clin Immunol. 2013 Oct;132(4):856-65.e1-3. doi: 10.1016/j.jaci.2013.05.008. Epub 2013 Jun 24. J Allergy Clin Immunol. 2013. PMID: 23806637 Free PMC article. - Treatment of patients with respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
Simon RA. Simon RA. Curr Allergy Asthma Rep. 2004 Mar;4(2):139-43. doi: 10.1007/s11882-004-0059-4. Curr Allergy Asthma Rep. 2004. PMID: 14769263 Review. - Differential diagnosis of eosinophilic chronic rhinosinusitis.
Sok JC, Ferguson BJ. Sok JC, et al. Curr Allergy Asthma Rep. 2006 May;6(3):203-14. doi: 10.1007/s11882-006-0036-1. Curr Allergy Asthma Rep. 2006. PMID: 16579870 Review. - Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors.
Weller CL, Collington SJ, Brown JK, Miller HR, Al-Kashi A, Clark P, Jose PJ, Hartnell A, Williams TJ. Weller CL, et al. J Exp Med. 2005 Jun 20;201(12):1961-71. doi: 10.1084/jem.20042407. Epub 2005 Jun 13. J Exp Med. 2005. PMID: 15955837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous